Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial enzyme systems involved in glucose and pyruvate metabolism are crucial for bacterial survival, enabling energy extraction from carbohydrates and adaptation to varying environmental conditions. These systems encompass glycolysis, the TCA cycle, and alternative pathways like the Entner-Doudoroff pathway. Key enzymes include glucokinase, phosphofructokinase, pyruvate kinase, pyruvate dehydrogenase, and various enzymes involved in amino acid biosynthesis and gluconeogenesis. Regulation is primarily achieved through allosteric control by metabolites like fructose 1,6-bisphosphate and AMP. Targeting these enzymes can disrupt bacterial metabolism and potentially serve as an antimicrobial strategy, but careful consideration of off-target effects and resistance mechanisms is essential.
Inhibition of specific enzymes within the glucose or pyruvate metabolism pathways, leading to disruption of bacterial energy production or biosynthesis.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial Enzyme Systems Involved in Glucose and Pyruvate Metabolism (N/A).